Tyber Medical LLC, Intech, and Resolve Surgical Technologies are merging together as a global medical device supplier.
The merger is being supported by Montagu, a mid-market private equity firm. As part of the merger Montagu has also entered into a definitive agreement to acquire Tyber Medical. Montagu already has an existing investment in Resolve and Intech. Tyber Medical will be combined with these existing investments, subject to customary regulatory approvals and closing conditions.
Montagu Partner Adrien Sassi commented, “Montagu is proud to support the creation of this world-class medical device platform. The three organizations share similar passion and focus on delivering innovative, high-quality, reliable solutions to OEM [original equipment manufacturer] customers, surgeons, and patients.”
Sassi continued, “We look forward to partnering with Jeff Tyber and his talented team, as well as extending our successful collaboration with Intech and Resolve.”
Established in 2012, Tyber Medical is an orthopedic device manufacturer. Serving the spinal extremity, and trauma markets the company, per the press release, provides access to “FDA-cleared and CE-marked, private label, portfolio-enhancing regulatory-approved orthopaedic implants.” Tyber Medical has released over 50 systems for the spine, extremity, and trauma markets.
Intech is a global company with manufacturing facilities in the United States, Europe, and Asia-Pacific. It produces both orthopedic devices and mission-critical components.
Resolve is a private label OEM serving the orthopedic, spine, and cardiothoracic markets. The company, per the press release, “designs, develops and manufactures metal and polymer implants and instruments.”
Together the three companies will support OEM customers by providing scalable services and market-cleared technologies. According to the press release, the combined company “will be a leading contract supplier of systems for Spine, Trauma, Extremities, Sports Medicine and Enabling Technologies.”
Resolve President and CEO Megan Osorio commented, “Bringing innovation to market with speed and quality is of the utmost importance to our OEM customers.”
Osorio continued, “Joining forces will increase our ability to support their growth across the full range of orthopaedic implants & instruments by bringing the deep experience of our respective teams and scale of our manufacturing footprint together.”
